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INTRODUCTION 
 
The indications for intervention in the management of patients with 
ureteric calculi have clearly been affected by the increased efficiency and 
lower morbidity of minimally invasive treatment modalities. Although 
the traditional indications for intervention (intolerable or intractable 
symptoms, infection, obstruction, and a stone that is unlikely to pass 
spontaneously) have not changed, the array of technologies currently 
available allows almost any symptomatic patient to be considered a 
candidate for stone removal.  
Lingeman and associates reported that when a patient requires 
hospitalization, it is less costly to remove the patient's stone with either 
SWL or ureteroscopy than to attempt to control the patient's symptoms 
with pharmacotherapy only. However, many patients will pass the stone 
spontaneously1. A thorough knowledge, then, of the natural history of 
ureteric stones permits a well-informed judgment of when conservative 
measures (e.g., observation), rather than intervention, are indicated. 
Furthermore, such data help the patient consider the spectrum of options 
and decide whether to try to endure further symptoms or to elect 
immediate stone removal 3, 4. 
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In the absence of external ureteric compression or internal 
narrowing, the width of the stone is the most significant measurement 
affecting the likelihood of stone passage (Ueno et al, 1977). The 
likelihood of spontaneous stone passage was directly related to stone size 
and location at the time of presentation. The rate of spontaneous passage 
for stones smaller than 4 mm was 38% compared with 1.2% for those 
larger than 6 mm, irrespective of their position in the ureter at the time of 
presentation. Calculi discovered in the distal third of the ureter had a 
spontaneous passage rate of 45%, compared with 22% for the middle 
third and 12% for the proximal third. Two thirds of all stones that passed 
did so within 4 weeks after the onset of symptoms. 
Segura5 and associates reported on the management of patients 
with ureteric calculi that for patients with stones of 5 mm or less, 
conservative management should be considered, whereas the chance of 
spontaneous passage for larger stones diminishes considerably, and 
intervention is recommended.  
The factors that  must be considered when recommending 
treatment to patients with ureteric calculi may be grouped into three 
broad categories: stone-related factors (location, size, composition, 
duration, and degree of obstruction), clinical factors (the patient's 
tolerance of symptomatic events, the patient's expectation, associated 
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infection, single kidney, abnormal ureteric  anatomy, and technical 
factors (equipment available for treatment, costs). These factors may be 
thought of as treatment modifiers; the presence or absence of one or more 
of these factors may shift the balance toward a certain treatment modality. 
Perhaps the greatest dilemma facing the urologist today is “to blast 
or not to blast” (i.e., to choose between the two most frequently used 
modalities in ureteric stone treatment—SWL and ureteroscopy). 
 Success of ESWL has been correlated with radio density of 
the stone on plain X-ray KUB.  Overall accuracy of predicting calculi 
composition from plain radiographs was reported to be only 39% which 
is at present insufficient for clinical use. 
The Emergence of Non Contrast CT KUB in the assessment of 
flank pain and the subsequent availability of the attenuation coefficient 
measurement has made several authors comparing attenuation and stone 
composition invitro.  These studies have determined that stone 
compositions can be predicted on the basis of the attenuation value 
determined by NCCT. 
The density of stone measured by NCCT stone Hounsfield Unit 
(HU) varies with composition and determines the fragility of a calculus 
which ultimately governs the clinical outcome in ESWL. NCCT because 
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of its easy availability, superb sensitivity and very high resolution 
capability it is a good modality for the measurement of stone density. 
The optimal therapy for patients requiring removal of distal 
ureteric calculi is controversial. SWL and ureteroscopy are both effective 
treatments associated with high success rates and limited morbidity. 
ESWL is noninvasive, associated with less morbidity than ureteroscopy. 
Moreover ureteroscopy requires specialized training, requires more 
anaesthesia, and more often requires ureteral stent placement. 
 A 1997 meta-analysis performed by the AUA Ureteral Stones 
Clinical Guidelines Panel established that both ureteroscopy and SWL are 
acceptable treatment options for patients with distal ureteric stones. This 
recommendation was based on the stone-free results, morbidity, and re-
treatment rates for each respective therapy. However, this report used 
data that were derived from older lithotripsy and endoscopic technology 
Continued studies are warranted to better define the roles of ESWL 
and ureteroscopy in the management of patients with distal ureteric 
calculi because both are highly effective. 
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AIM AND OBJECTIVE 
 
The aim of this study is to 
 
1) To analyze the efficacy of Extra corporeal lithotripsy in the 
management of lower ureteric calculus 
 
2) To find out ideal patients for  extracorporeal shock wave 
lithotripsy in the management of lower ureteric calculus 
 
3) To find out complications of extracorporeal shock wave 
lithotripsy during the management of lower ureteric calculus 
 
 
 
 
 
               
6 
 
                     
REVIEW OF LITERATURE 
 
 The goal of the surgical treatment of patients suffering from 
ureteric calculi is to achieve complete stone clearance with minimal 
attendant morbidity. Improvements in surgical technology, such as SWL, 
rigid and flexible ureteroscopes, the holmium:YAG laser, and basket 
devices, have greatly augmented the urologist's ability to efficiently treat 
such patients, regardless of the size or location of the ureteric calculus.
  Minimally invasive treatments replaced the open stone surgery 
nowadays. Extra Corporeal Shockwave Lithotripsy is a non invasive 
treatment option with minimal morbidity. 
 The word Lithotripter is Greek origin and means stone crusher. 
Lithotripters have evolved from many years of research into physics of 
flight. Researchers discovered that raindrops striking an air craft during 
supersonic flight created shockwaves that had disintegrating effects on 
solid materials. Refinements of these findings led to the invention of the 
Lithotripter as a means for treating urinary calculi.  
 In February 1980 Dr.Christian Chaussay, University of Munich 
first used electrically generated focused shockwaves to fragment stones 
within a human kidney. The first experimental treatment began the era of 
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ESWL. The first Lithotripter model HM 1 soon replaced by HM 2 in 
1982 and in 1984 by Model HM 3. Each new generation reflects 
progression of technology and a growing sophistication. Further 
modification of the generation is the consolidation of fluoroscopic 
screens and the lithotripsy control into a convenient, efficient and user 
friendly console. Shockwave lithotripsy technology has advanced rapidly 
in terms of shock wave generation, focusing, patient coupling and stone 
localization making it the most widely used treatment for renal and 
ureteric calculi. 
METHODS AND PHYSICAL PRINCIPLES OF SWL  
 In extracorporeal SWL, shockwaves are generated by a source 
external to the patient's body and are then propagated into the body and 
focused on a kidney or ureteric stone. The uniqueness of this device is in 
its exploitation of shockwave focusing. Relatively weak, nonintrusive 
waves are generated externally and transmitted through the body. The 
shockwaves build to sufficient strength only at the target, where they 
generate enough force to fragment a stone. 
 When energy is deposited rapidly into a fluid, a shockwave 
invariably results. Shockwaves are surfaces that divide material ahead, 
not yet affected by the disturbance, from that behind, which has been 
compressed as a consequence of energy input at the source. These waves 
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move faster than the speed of sound, and the stronger the initial shock, 
the faster the shockwave moves. Their behavior is characteristic of the 
propagation of nonlinear waves. Although the shockwaves in lithotripters 
generate large pressures, they are relatively weak in that they induce only 
slight compression and deformation of a material. 
GENERATOR TYPE  
 There are three primary types of shockwave generators: electro 
hydraulic (spark gap), electromagnetic, and piezoelectric. 
 
ELECTRO HYDRAULIC (SPARK GAP) GENERATORS 
 A spherically expanding shockwave is generated by an underwater 
spark discharge High voltage (15000-25000V) is applied to two opposing 
electrodes positioned about 1 mm apart. The high-voltage spark discharge 
causes the explosive vaporization of water at the electrode tip. For the 
spherically expanding shockwave to be focused onto a calculus, the 
electrode is placed at one focus (termed F1) of an ellipsoid, and the target 
(the stone) is placed at the other focus (termed F2). Hemi ellipsoid 
reflector focuses shockwaves from F1 to target F2. Advantage of this 
generator is effectiveness in breaking kidney stones. Disadvantages are 
substantial pressure fluctuations from shock to shock and a relatively 
short electrode life. Another issue to consider is that as the electrode 
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deteriorates, it wears down, and a 1-mm displacement of the electrode tip 
off of F1 can shift F2 up to 1 cm off of the initial target. 
 
ELECTROMAGNETIC GENERATORS 
 The electromagnetic generators produce either plane or cylindrical 
shockwaves. The plane waves are focused by an acoustic lens the 
cylindrical waves are reflected by a parabolic reflector and transformed 
into a spherical wave. 
  Basic design of an electromagnetic generator is simple, a water-
filled shock tube containing two conducting cylindrical plates separated 
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by a thin insulating sheet. When an electrical current is sent through one 
or both of the conductors, a strong magnetic field is produced between 
the conductors, moving the plate against the water and thereby generating 
a pressure wave. The electromagnetic force that is generated, termed 
magnetic pressure, causes a corresponding pressure (shockwave) in the 
water. The shock front produced is a plane wave that is of the same 
diameter as the current-carrying plates. The energy in the shockwave is 
concentrated onto the target by focusing it with an acoustic lens. 
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 The electromagnetic system that uses a cylindrical source also has 
a coil (cylindrical in shape) surrounded by a cylindrical membrane that is 
pushed away from the coil by the induction of a magnetic field between 
the two components. In both systems, the pressure pulse has only one 
focal point (F2) that is positioned on the target. 
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ADVANTAGES 
 Electromagnetic generators are more controllable and reproducible 
than electro hydraulic generators because they do not incorporate a 
variable in their design such as the underwater spark discharge. Other 
advantages include the introduction of energy into the patient's body over 
a large skin area, which may cause less pain. In addition, a small focal 
point can be achieved with high-energy densities, which may increase its 
effectiveness in breaking stones. This generator will deliver several 
hundred thousand shockwaves before servicing, thereby eliminating the 
need for frequent electrode replacement, which is required with most 
electro hydraulic machines.  
DISADVANTAGE 
 Small focal region of high energy results in an increased rate of 
subcapsular hematoma formation. 
PIEZOELECTRIC GENERATOR 
 Piezoelectric lithotripter also produces plane shockwaves with 
directly converging shock fronts. These generators are made of a mosaic 
of small, polarized, polycrystalline, ceramic elements (barium titanate), 
each of which can be induced to rapidly expand by the application of a 
high-voltage pulse. Owing to the limited power of a single piezoelectric 
element, 300 to 3000 crystals are necessary for the generation of a 
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sufficiently large shock pressure. The piezoelectric elements are usually 
placed on the inside of a spherical dish to permit convergence of the 
shock front. The focus of the system is at the geometric center of the 
spherical dish. 
 
 
ADVANTAGES 
 Focusing accuracy, a long service life, and anaesthesia free 
treatment. 
DISADVANTAGES 
 Insufficient power it delivers hampers its ability to effectively 
break renal stones.  
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SHOCK WAVE COUPLING 
 Shock waves can be coupled effectively into body by degassed 
water which has matched acoustic impedance to soft tissues. Current 
Lithotripter use enclosed water cushion with a coupling medium of 
ultrasound gel instead of 1000 L water bath. Shock wave attenuation 
through the membrane of water cushion amounts to 20% loss of energy. 
 
STONE LOCALIZATION 
 Stone localization during lithotripsy is accomplished with either 
fluoroscopy (or) ultrosonography.  Fluroscopy provide the urologist with 
a familiar modality, added benefit of effective ureteric stone localization. 
Disadvantages are ionizing radiation to both the patient and medical staff, 
and it is not useful in localizing radiolucent calculi. 
Ultrasonography based Lithotripters offer the advantages of stone 
localization with continuous monitoring and effective identification of 
radiolucent stones without radiation exposure. Disadvantage of 
ultrasonography is not able to locate ureteric stones.  
 
PHYSICAL PROPERTIES OF RENAL CALCULI AND TISSUE 
 Knowledge of acoustic and mechanical properties of renal, ureteric 
calculi and tissue is important to understand shockwave – stone tissue 
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interaction and the mechanisms of stone fragmentation and tissue injury 
during ESWL. Acoustic properties determine the characteristics of shock 
wave propagation inside the stone and tissue materials as well as the 
wave transmission and reflection, at the stone tissue boundary. 
Mechanical properties dictate the response of the stone and tissue 
materials to shock wave loadings. Acoustic and mechanical properties of 
calculi depend primarily on the composition of stone. 
 
COMPOSITION AND STRUCTURAL FEATURES OF CALCULI 
 The constituents of renal calculi are crystalline (95%) and non 
crystalline matrix materials (Protein, Cellular debris and organic 
materials).Major crystalline components are calcium oxalate 
(Monohydrate and dihydrate), phosphates (hydroxyapatite, carbonate 
apatite - struvite) uric acid, cystine and xanthine. Calculi appear in wide 
range of shapes, sizes, colors and textures.  
ACOUSTIC PROPERTIES OF CALCULI AND RENAL TISSUE 
 Acoustic properties are density, wave speed and acoustic 
impedance. Longitudinal wave propagation (compression) characterized 
by parallel movements of material particles along the wave path. 
Transverse (Shear) wave propagation material particles move 
perpendicularly to wave path.  
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 Calcium oxalate monohydrate and cystine stones have higher 
acoustic impedance. Stones with higher acoustic impedance would 
produce a stronger reflection of the shock wave at the anterior surface of 
stone resulting in less of the shock wave energy being transmitted into the 
stone to cause fragmentation. 
MECHANICAL PROPERTIES OF CALCULI 
 Dynamic elastic properties of calculi depends upon resistance of 
stone material to elongation (or) shortening, shear deformation and 
volume change. Most renal calculi are brittle while cystine stones are 
ductile (more energy is needed to produce fracture) so most difficult to 
fragment during SWL. 
 
MECHANISMS OF VARYING STONE FRAGILITY 
 Stone fragility determines the response of a ureteric calculus to 
SWL. Response varies with composition, size, and structural features of 
stone. 
 It has been reported that stone with homogenous structure are less 
fragile than stones with heterogeneous structure. Elastic module 
determine a stones resistance to shock wave induced deformation, 
hardness determine a stone’s resistance to cavitation, microjet impact and 
fracture toughness determines a stone’s resistance to spalling damage and 
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crack propagation. Calcium oxalate monohydrate and brushite stones are 
less fragile than MAP (Magnesium ammonium phosphates) and CA 
(Carboxy apatite) stones because Calcium oxalate monohydrate and 
brushite stones are stiffer, harder and more resistant to fracture. Based on 
the above factors cystine stones are most ESWL resistant, next are 
Brushite, and Calcium Oxalate Monohydrate. 
MECHANISMS OF STONE FRAGMENTATION 
Present knowledge in the field of SWL suggests that comminution of a 
renal or ureteric stone in a lithotripter field is the consequence of failure 
of the stone material due to the mechanical stresses produced either 
directly by the incident shockwave or indirectly by the collapse of 
cavitation bubbles. These events could be occurring simultaneously or 
separately at the surface of the stone or within the interior of the stone. 
Several potential mechanisms for SWL stone breakage have been 
described: spall fracture, squeezing, shear stress, superfocusing, acoustic 
cavitation, and dynamic fatigue. 
 Shock waves composed of positive compressive waves and 
negative tensile waves. Initial short and steep compressive front with 
pressures of about 40 MPa that is followed by a longer, lower amplitude 
negative (tensile) pressure of 10 MPa, with the entire pulse lasting for 
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duration of 4 μs. Note that the ratio of the positive to negative peak 
pressures is approximately 5. Pressure measurements near the focal 
region of a Dornier unmodified HM3 indicate a 6-dB beam, of a width of 
approximately 15 mm. Since most of renal and ureteric stones are also 
generally of this dimension, the wave front incident on the stone can be 
considered a plane wave.  
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 The first mechanism by which a stone might break is through spall 
fracture. Once the shockwave enters the stone, it will be reflected at sites 
of impedance mismatch. One such location is at the distal surface of the 
stone at the stone-fluid (urine) interface (although there could be other 
internal sites, such as cavities in the stone and interfaces of crystalline 
and matrix materials). As the shockwave is reflected, it is inverted in 
phase to a tensile (negative) wave. If the tensile wave exceeds the tensile 
strength of the stone, there is an induction of nucleation and growth of 
microcracks that eventually coalesce, resulting in stone fragmentation, 
which is termed spallation. The failure plane is located perpendicular to 
the applied tensile stress. 
 Second mechanism for stone breakage, termed squeezing-splitting 
or circumferential compression, occurs because of the difference in sound 
speed between the stone and the surrounding fluid. The shockwave inside 
the stone advances faster through the stone than the shockwave 
propagating in the fluid outside of the stone. The shockwave that 
propagates in the fluid outside of the stone thus produces a 
circumferential force on the stone, resulting in a tensile stress in the stone 
that is at its maximum at the proximal and distal ends of the stone. The 
resulting squeezing force could split the stone either in a plane parallel to 
the shockwave propagation direction or, depending on the elastic 
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properties of the stone, possibly in a plane parallel to the shockwave 
front. It has been theorized that squeezing should be enhanced when the 
entire stone falls within the diameter of the focal zone. Thus, current 
third-generation lithotripters that have very small focal zones will not 
make use of this mechanism, as the stone size is typically greater than the 
focal zone, whereas the original Dornier HM3 machine would. 
 The third mechanism is shear stress. Shear stress will be generated 
by shear waves (also termed transverse waves) that develop as the 
shockwave passes into the stone. The shear waves propagate through the 
stone and will result in regions of high shear stress inside the stone. In 
contrast to compression waves, which move the molecules in the 
direction of propagation, a shear wave results in translation of molecules 
transverse to the direction of propagation, and therefore the molecules are 
not compressed but are shifted sideways by the wave. Many materials are 
weak in shear, particularly if they consist of layers, as the bonding 
strength of the matrix between layers often has a low ultimate shear 
stress. Calcium oxalate stones commonly possess alternating layers of 
mineral and matrix, and the shear stress induced by the transverse wave 
could cause such stones to fail. 
 The fourth mechanism for stone breakage, superfocusing, is the 
amplification of stresses inside the stone due to the geometry of that 
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stone. The shockwave that is reflected at the distal surface of the stone 
can be focused either by refraction or by diffraction from the corners of 
the stone. 
 The fifth potential mechanism for SWL stone breakage is 
cavitation 14. Cavitation is defined as the formation and subsequent 
dynamic behaviour of bubbles. The lithotripter-generated pressure field 
has been found to induce cavitation in both in vitro and in vivo studies. 
The negative pressure in the trailing part of the pulse causes bubbles to 
grow at nucleation sites. A nucleation site is an inhomogeneity in the 
fluid, which leads to preferential formation of free gas under stress. 
During the negative pressure wave, the pressure inside the bubble falls 
below the vapour pressure of the fluid, and the bubble fills with vapour 
and grows rapidly in size (almost three orders of magnitude). As these 
bubbles grow, they oscillate in size for about 200 μs and then collapse 
violently, giving rise to high pressures and temperatures. In the absence 
of any boundaries, a cavitation bubble remains spherical during collapse, 
releasing energy primarily by sound radiation, the majority of which is in 
the form of a shockwave However, in the presence of a boundary, a liquid 
jet, also termed a cavitation microjet, forms inside the bubble during the 
collapse. This jet can accelerate to extremely large speeds because it 
converts most of its kinetic energy from the collapse of the cavity 
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interface to the jet itself. If the liquid jet is near the surface of a stone, it 
creates a locally compressive stress field in the stone, which propagates 
spherically into the stone interior. 
 The final mechanism of stone fragmentation to be considered 
defines stone breakage in terms of a dynamic fracture process, in which 
the damage induced by SWL accumulates during the course of the 
treatment, leading to the eventual destruction of the stone. Essential to 
this process is nucleation, growth, and coalescence of flaws within the 
stone caused by a tensile or shear stress. As renal calculi are not 
homogeneous but rather have either a lamellar crystalline structure 
bonded by an organic matrix material or an agglomeration of crystalline 
and noncrystalline material, there are numerous sites of pre-existing flaws 
(microcracks). All of the fracture mechanisms described have the 
potential to generate progressive damage to the interior of the stone. 
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Stone fragmentation varies according to stone composition cystine 
stones are most ESWL resistant. Next are Brushite, and Calcium Oxalate 
Monohydrate. Pre treatment determination of stone composition and an 
ability to predict the probability of fragmentation can reduce the number 
of fruitless shockwaves and reduce the overall cost of stone management.  
 Different techniques have been used to assist in determining the 
chemical composition of urinary calculi in vivo.  Such tests include pH, 
identifying characterizing urinary crystals, presence of urea splitting 
organisms, bone densitometry and radiographic studies. 
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 Roentgenography has played a major role in the diagnosis and 
management of calculus disease. Various researchers have attempted to 
predict the stone composition by different methods. 
In 1996 Dretler 24and Kolt further analyzed radiographic patterns 
of calcium oxalate dihydrate and monohydrate stones. Smooth edge, 
denser than bone, homogenous are pure calcium oxalate monohydrate 
stones. Radial striations and superimposed stippling pattern in calcium 
oxalate dihydrate stones. This study is the first proof that radiographic 
morphology can be related to ESWL stone free rate.   
 
 Hillman 25and his associate sought to determine the feasibility of 
using CT to analyze the chemical composition of renal calculi. He 
concluded that uric acid stone can be differentiated clearly from struvite 
and calcium oxalate calculi. (CT number (or) Hounsfield unit is 
calculated using the formula). 
1000 x  μtissue  -- μ water 
μ Water  
  
 μ - absorption coefficient in kilovoltage. This number is named in 
honor of Godfrey Hounsfield the inventor of CT Scanning when HUs are 
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used air has a value of – 1000,  water- 0 and dense bone and calcification   
> + 1000. 
 
 Federle et al 26 evaluated 9 Patients and analyzed CT HU with 
stone composition. In this study uric acid stone has an attenuation value 
between 346-400 HU, Xanthine stone had a value of 391 HU, Cystine 
stone 586 HU, Calcium oxalate 500-1000 HU. 
 
 Kuwahara et al 27studied the attenuation value of CT of 50 calculi 
more than 1cm in diameter to determine its composition. The attenuation 
of various calculi were measured in HU in 5mm collimation in the region 
of interest. Values obtained as follows. Mixed calcium oxalate Phosphate 
1555+193, Magnesium Ammonium Phosphate 1285+284, calcium 
oxalate 1690, Calcium Phosphate 1440, Cystine 757+114. Uric acid 480. 
They concluded that attenuation values ranging from 500-1600 
overlapped for various calculi. However uric acid calculi had attenuation 
value less than 500 and oxalate calculi >1000. 
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EXTRACORPOREAL SHOCK WAVE TREATMENT OF URETERIC 
CALCULI 
 Chaussy and his colleagues initially treated ureteric stones insitu 
and reported < 50% success rate. Most of the stones had been 
disintegrated, but the pieces were held together by edematous mucosa. 
This was seen in patients with stones impacted. This observation led 
Chaussy to use ureteric catheter or ureteroscope to push the ureteric stone 
into the renal collecting system. The success of this treatment was 75%-
95%28. 
ASSESSMENT OF FRAGMENTATION 
 One of the troublesome aspect of ESWL is determining the 
adequacy of fragmentation. One of the best indications is dispersion of 
sand, but this can occur only if the stone is located in a large cavity such 
as renal pelvis. Barr et al 1990 noted that both Calyceal and Ureteric 
stones may be fragmented satisfactorily, but radiographic appearance 
may appear unchanged. Hence even if the 24-hour post treatment plain 
radiograph shows no definite pulverization the patient should be followed 
for a couple of weeks before considering retreatment.  
IMPACTED URETERIC STONES 
 An impacted stone may be defined as a stone that cannot be 
bypassed by a wire or catheter or a stone that remains at the same site in 
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the ureter for more than 2 months.  The presumed action of shockwaves 
on a stone is the creation of interacting compressive and tensile forces at 
fluid stone interfaces. Stone fragment is torn off in layers. Green and 
Lytton,1985 &Farsi et al, 1994 in their study noticed that impacted stones 
are often more resistant to fragmentation by SWL .One explanation for 
this observation is expansion space theory the initial shock waves 
remove an outer layer of stone material, but the surrounding ureteric 
walls do not allow these particles to fall away. The new fluid –stone 
interfaces interfere with the transmission of next series of shock waves to 
the core of the stone, thereby preventing complete fragmentation. This 
situation can be remedied by push back to kidney with a ureteric catheter 
or ureteroscope, by bypassing the stone with a ureteric catheter to provide 
an artificial expansion space, or by irrigating the stone during insitu 
ESWL using saline to flush the particles away from the solid core. The 
only disadvantage to ureteric irrigation is that renal pelvic pressure may 
raise enough to result in forniceal tear and extravesation. 
  Both Mueller and associates (1986) and Park and colleagues 
(1998) have performed in vitro studies demonstrating that the 
confinement of a model stone is associated with substantial reduction in 
fragmentation, which may be due to the lack of a liquid interface 
surrounding the stone, thus reducing cavitation activity. 
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 Although these reports suggest that ureteroscopy may be the 
optimal approach to the impacted ureteric stone, some urologists still 
favor SWL as the initial approach for stones smaller than 1 cm in the 
ureter. However, ureteroscopy may be the treatment of choice for patients 
whose SWL treatment failed, for patients with cystinuria, for patients 
with distal obstruction, for patients with impacted stones, for obese 
patients, for patients with bleeding diathesis, and when SWL is not 
readily available. 
 Cole and Shuttleworth reported on insitu ESWL on 40 patients 
juxta vesical uretric stones. Unmodified Dornier HM3 lithotripter was 
used in the treatment.33 stones ≥ 8mm, one below 5mm.Satisfactory 
disintegration occurred with one treatment in 90% of patients. At end of 3 
months 79% of patients were stone free. 
 The ultimate goal of ESWL is to fragment renal and ureteric calculi 
as effectively as possible with minimizing the potential injury to 
surrounding tissues. 
 AUA guidelines on the management of patients with ureteric 
calculi that for stones smaller than 5 mm, the spontaneous passage rate in 
the distal ureter ranged from 71% to 98% whereas stones larger than 5 
mm had a lower spontaneous passage rate, ranging from 25% to 53%. 
These rates have been affirmed by a more recent review of CT imaging of 
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ureteric calculi by Coll et al, 2002. Therefore, for patients with stones of 
5 mm or less, conservative management should be considered, whereas 
the chance of spontaneous passage for larger stones diminishes 
considerably, and intervention should be more readily contemplated. 
 Patients with ureteric stones >10 mm could be observed or treated 
with MET, but in most cases such stones will require surgical treatment. 
No recommendation can be made for spontaneous passage (with or 
without medical therapy) for patients with large stones. 
For patients requiring stone removal, AUA recommends: 
Standard: A patient must be informed about the existing active treatment 
modalities, including the relative benefits and risks associated with each 
modality. [Based on Panel consensus/Level IV] 
 Specifically, both SWL and URS should be discussed as initial 
treatment options for the majority of cases. Regardless of the availability 
of this equipment and physician experience, this discussion should 
include stone-free rates, anaesthesia requirements, need for additional 
procedures, and associated complications. Patients should be informed 
that URS is associated with a better chance of becoming stone free with a 
single procedure, but has higher complication rates. 
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Recommendation: For patients requiring stone removal, both SWL 
and URS are acceptable first-line treatments. (Based on review of the 
data and Panel consensus/Level 1A-IV).  
 El-Faqih et al (1988) studied treatment of juxtavesicular uretric 
stones. They compared URS and ESWL. The stone free rate in the 
ureteroscopy group was 93%,while ESWL group was 90%.These authors 
suggest ESWL  should be the primary mode of intervention in patients 
with distal ureteric calculus.  
 V.J. GNANAPRAGASAM et al U.K in his study of primary in 
situ extracorporeal shock wave lithotripsy in the management of ureteric 
calculi: reviewed   treatment outcome in 180 patients with 196 stones 
who were treated with primary in situ ESWL in all level of ureteric 
calculus. At 3 months follow up stone free rates were 90% for upper 
ureteric calculus, 89% for mid ureteric calculus and 86% for lower 
ureteric calculus. He concluded that where prompt access to ESWL 
available, primary in situ ESWL remains an effective form of treatment 
for all ureteric calculi, although stone free rates are lower for larger 
stones39.  
 Mohammad Ghafoor and colleagues from TAWAM hospital, 
UAE studied the efficacy of extracorporeal shock wave lithotripsy in the 
treatment of ureteric stones. Based on stone size, the patients were 
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divided into two groups: A (10 mm) and B (11-20 mm). Their results 
were overall clearance rate for ureteric stones treated with ESWL, 
irrespective of its site and size was 78.5%. Clearance rate for small stones 
(<10mm) in the lower third of the ureter was 73.8% and for stones larger 
than 10 mm in the distal third of ureter, the clearance rate was low with a 
high retreatment rate40. 
 They concluded that for distal ureteric stones <10 mm in diameter, 
the clearance rate is more than 70% and ESWL can be considered as a 
primary treatment, while for stones larger than 10 mm in diameter, 
endoscopic removal should be the preferred treatment. 
 Guang –Qiao ZENG and Wei-De ZHONG from china compared 
the efficacy of URS and ESWL in the treatment of lower ureteric calculus 
.180 patients underwent URS and 210 patients were submitted for ESWL 
in prone or at a major postero oblique position. Results after 1 month: 
Stone clearance was achieved in 164 patients (78.1%) ESWL group, 168 
patients (93.3%) in URS group (p- 0.05)29 
 Maheshwari PN et al  conducted study in  R.G stone research 
institute, Mumbai & New Delhi compared  success ,efficacy and 
complications of  URS & ESWL in symptomatic non obstructing lower 
ureteric calculus .120 patients under went ESWL ,after 3 months 90% of 
patients were stone free. URS was needed for 12 patients where ESWL 
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failed to achieve stone clearance. Hence they concluded that ESWL can 
be the primary mode of treatment for symptomatic small non obstructing 
lower ureteric calculus and URS can be offered to patients who demand 
immediate failure or when ESWL fails30. 
 
COMPLICATIONS 
 The complications of ESWL of uretric stones appear to be related 
to manipulative procedures done before or after ESWL. There are no 
confirmed reports of adverse effects associated with insitu ESWL of 
lower uretric calculi alone 31, 32, 33. 
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MATERIALS AND METHODS 
 
TITLE OF THE STUDY:  
Analysis of efficacy of extracorporeal shock wave lithotripsy in the 
management of lower ureteric calculus 
 
PERIOD OF STUDY: 
January 2008 –April 2010 
STUDY DESIGN:  
Prospective study 
SOURCE OF PATIENTS: 
The study was conducted in the Department of Urology; Government 
General Hospital from the patients those attended for the management of 
lower ureteric calculus. The institutional review board at our hospital 
approved the study. 
 
METHOD OF STUDY: 
Informed consent obtained from all the patients after explaining all 
available modalities of treatments –medical expulsion therapy, 
ureteroscopy &intracorporeal lithotripsy and extracorporeal lithotripsy, 
their complications in the management of lower ureteric calculus. 
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PATIENT EVALUATION: 
 History, Physical examination, Complete hemogram,Urine routine 
and culture sensitivity, Renal function test, X ray KUB, Ultra sonogram 
KUB, CECT KUB. Patient’s details are entered in a proforma. 
Lower ureteric calculus –Stones below sacroiliac joint to vesico 
ureteric junction. Stone size measurements taken in the study–maximal 
transverse measurement in C.T and   C.T –H.U of stones were measured 
simultaneously.  
 Patients included in the study are divided into 2 groups based on 
stone size. Group 1:≤10 mm and Group 2:  >10mm. Patients again 
divided based on C.T –H.U into Groups A and B, Group A: ≤1000 Group 
B :> 1000 H.U. 
 Hence study group contains, 
Group 1A: ≤10 mm and H.U:≤1000, 
Group 1 B: ≤10mm and H.U > 1000,  
Group 2A:  >10 mm and H.U:≤1000,  
Group 2 B: >10mm and H.U > 1000. 
 
INCLUSION CRITERIA: 
1. Patients with unilateral lower ureteric calculus willing for 
extracorporeal shockwave lithotripsy 
2. Patients with normal renal parameters 
3. No previous treatments for the same ureteric calculus 
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EXCLUTION CRITERIA: 
1. Not willing for ESWL 
2. Bilateral ureteric calculi 
3. Ureteric obstruction distal to calculus 
4. Coagulation disorder/patients on anticoagulation drugs 
5. Pregnancy 
6. Sepsis 
7. End stage renal disease 
 
PATIENT PREPARATION & ESWL: 
Bowel preparation – anti flatulent & laxatives day before procedure 
All treatments were done with Donier Compact Delta II 
(Electromagnetic Generator) machine as outpatient procedure.  
POSITION OF PATIENT: 
Prone 
ANAESTHESIA/ANALGESIA: 
Inj.Pentazocine 30 mgs and Inj. Promethazine hcl 25 mgs intramuscularly          
30 minutes before the procedure. 
 Stone focusing done fluoroscopically 
2500 shocks for all patients - 60 shocks/minute, in the intensity 4-5. 
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POST PROCEDURE: 
After each session of treatment patients were observed for 4-6 
hours period and allowed to go home. Patients were explained about the 
post treatment hematuria, dysuria and passing stone fragment in the urine. 
Patients advised to take adequate oral fluids.  
FOLLOWUP: 
 Patients were followed in 15 days, 30 days, and 60 days and in 90 
days or whenever patients had unusual urinary complaints after the 
procedure. Failure of  ESWL –if any significant residual stone after 3 
months. 
History, Physical examination, U/S KUB, X ray KUB done during 
all visits. During the first visit in 15 days, adequacy of fragmentation 
assessed, if necessary second sitting of ESWL suggested.  
Patients follow up terminated if the patient cleared the stone with 
ESWL or secondary treatment selected for the failure of ESWL. 
STUDY ANALYSIS: 
 Study data analyzed using SPSS (V: 17) software. 
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OBSERVATION & RESULTS 
 
The study comprised of 50 patients who had satisfied the inclusion 
and exclusion criteria. 2 patients lost follow up after ESWL procedure, 
hence results of 48 patients analyzed. 
 
                                        AGE DISTRIBUTION 
 
Age of the patients ranged from 17-70 yrs, most patients were in 21-50yrs 
 
 
 
 
 
 
 
 
 
 
 
AGE (YRS) NO OF PATIENTS 
<20 6 
21-30 19 
31-40 8 
41-50 10 
51-60 4 
>60 1 
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                                     SEX DISTRIBUTION 
  
There were 35 male and 13 female patients in our study 
 
 
  
 
 
 
SEX  SIZE  
Total 
 Group 1      
≤ 10 mm 
Group 2    
> 10 mm 
 
 
 
 
 
MALE  19 16 35 
 76.0% 69.6% 72.9% 
FEMALE  6 7 13 
 24.0% 30.4% 27.1% 
 TOTAL  25 23 48 
 100.0% 100.0% 100.0% 
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SYMPTOM DISTRIBUTION 
 
Majority of patients presented with colicky pain and nausea/vomiting, 
other symptoms were dysuria and loin pain. Duration of symptoms 
ranged from 4 days to 1month.   
 
SYMPTOM NO OF PATIENTS 
COLICKY PAIN 45 
NAUSEA/VOMITING 42 
DYSURIA 7 
LOIN PAIN 2 
 
STONE SIZE DISTRIBUTION 
 
 In our study size of the lower ureteric calculus range from 6mm-
16mm.Cases are divided into 2 groups based on stone size.  Group  
1: ≤10mm and Group 2 : >10mm. 
  
SIZE NO OF PATIENTS 
Group 1: ≤10mm 25 
Group 2: >10mm 23 
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                                     CT HU DISTRIBUTION 
 
In Group 1(≤ 10mm), 24 patients were with ≤1000 HU - Group 1A and 1 
patient with >1000 HU Group 1 B.  
In Group 2(>10mm) 16 patients were ≤1000 HU – Group 2 A and 7 
patients were with >1000 HU –Group 2 B. 
   SIZE  
Total 
   Group 1    
≤ 10 mm 
Group 2  
> 10 mm 
HU ≤1000  24 16 40 
% within 
SIZE (cms) 
96.0% 69.6% 83.3% 
> 1000  1 7 8 
% within 
SIZE (cms) 
4.0% 30.4% 16.7% 
 Total  25 23 48 
% within 
SIZE (cms) 
100.0% 100.0% 100.0%
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SIDE DISTRIBUTION 
 
 In our study left side stones predominated (27pts) over right sided  
stones (21pts).   
 Group 1 ( ≤ 10 mm) -10 patients had right lower ureteric stones, 15 
had left side stones, Group 2( > 10 mm)  -11 patients had right sided 
stones and12 patients had left side stones. 
 
 SIDE  SIZE  
Total 
   Group 1
 ≤ 10 mm
Group 2  
> 10 mm 
 RIGHT  10 11 21 
% within SIZE 
(cms) 
40.0% 47.8% 43.8% 
LEFT  15 12 27 
% within SIZE 
(cms) 
60.0% 52.2% 56.3% 
 TOTAL  25 23 48 
% within SIZE 
(cms) 
100.0% 100.0% 100.0% 
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                                         PRIMARY TREATMENT 
 
In this study one patient in Group 1(≤10mm) required second sitting of 
ESWL. 
5 patients in Group 2 (>10mm) required second sitting.  
 
   SIZE  
Total 
   Group 1 
≤ 10 mm
Group 2  
> 10 mm 
NO OF 
PRIMARY 
ONE  24 18 42 
% within SIZE 
(cms) 
96.0% 78.3% 87.5% 
TWO  1 5 6 
% within SIZE 
(cms) 
4.0% 21.7% 12.5% 
 Total  25 23 48 
% within SIZE 
(cms) 
100.0% 100.0% 100.0%
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NO OF PRIMARY CT- HU 
 
No of primary treatment increased when CT HU was >1000(Group 1B 
& Group 2 B) when compared with CT- H.U < 1000(Group 1A & 
Group 2A) ,this difference was statistically significant (p-<0.01) 
 
 
                                                                                                    (P-<0.01) 
 
                                     
   HU 
Total    ≤1000 >1000 
NO OF 
PRIMARY 
ONE  37 5 42 
% within HU 92.5% 62.5% 87.5% 
TWO  3 3 6 
% within HU 7.5% 37.5% 12.5% 
 Total  40 8 48 
% within HU 100.0% 100.0% 100.0% 
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STONE FREE RATE –SIZE 
 
Stone free rate in ≤10mm group was 22/25patients (88%) and in >10mm 
group was 13/23 patients (56.5%).This difference was statistically 
significant (p-<0.01). 
     ESWL  SIZE   
   Group 1 
≤ 10 mm
Group 2  
> 10 mm Total
 SUCCESS  22 13 35 
% within SIZE 
(cms) 
88.0% 56.5% 72.9%
FAILURE  3 10 13 
% within SIZE 
(cms) 
12.0% 43.5% 27.1%
 Total  25 23 48 
% within SIZE 
(cms) 
100.0% 100.0% 100.0
% 
                                                                                                    
                                                                                                   (P-<0.01)     
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                                     STONE FREE RATE –HU 
 
                      STONE FREE RATE IN GROUP 1(≤ 10 mm) 
 
 In Group 1(≤ 10 mm) stone free rate based on C.T-H.U showed 
when C.T H.U  was ≤1000 success rate significantly higher than > 1000 
H.U. 
 
STONE FREE 
RATE 
≤1000 H.U 
GROUP 1 A 
> 1000 H.U 
GROUP 1 B 
TOTAL 
SUCCESS 22(91.7%) 0 22(88%) 
FAILURE 2(8.3%) 1(100%) 3(12%) 
TOTAL 24(100%) 1(100%) 25(100%) 
 
                                                                                                       P <0.001 
 
 
 
 
 
46 
 
                                       
                            STONE FREE RATE IN GROUP 2(> 10 mm) 
 
 In Group 2 (> 10 mm) stone free rate based on C.T –H.U showed 
when C.T -H.U was ≤1000 success rate was 75%, significantly higher 
than > 1000 H.U. (P <0.01) 
 
STONE FREE 
RATE 
≤1000 H.U 
GROUP 2 A
> 1000 H.U 
GROUP 2 B 
TOTAL 
SUCCESS 12(75%) 1(14.3%) 13(56.5%) 
FAILURE 4(25%) 6(85.71%) 10(43.5%) 
TOTAL 16(100%) 7(100%) 23(100%) 
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 When CT-HU increases success rate decreases, when HU was 
≤1000 (Group 1A & Group 2A) 34 patients (85%) successfully cleared 
their stones, failure occurred only in 6 patients (15%). 
 When HU > 1000(Group 1B &Group 2 B) only one patient cleared 
the stone (12.5%), failed in 7 patients (87.5%), this difference was 
statistically significant. 
   Stone free   rate:  HU  
   ≤1000 > 1000 Total 
 
 
 
SUCCESS  34 1 35 
% within 
HU 
85.0% 12.5% 72.9% 
FAILURE  6 7 13 
% within 
HU 
15.0% 87.5% 27.1% 
 Total Count 40 8 48 
% within 
HU 
100.0% 100.0% 100.0%
                                                                                            
                                                                                                    (P <0.001)                         
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                                        COMPLICATIONS   
 
During follow up of post ESWL, few patients presented with minor 
complications. Dysuria was the major complication in most number of 
patients-12 patients, hematuria in 5 patients, lower abdominal pain in 4 
patients and UTI in one patient. 
                           
COMPLICATIONS NO OF PATIENTS 
PAIN 4 
HEMATURIA 5 
DYSURIA 12 
UTI 1 
STRICTURE 0 
  
 
All complications were treated conservatively with hydration, antibiotics 
and analgesics. 
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                                                DISCUSSION 
 
ESWL has revolutionized the treatment strategy of urolithiasis 
world wide and continue to be a major therapeutic modality for treating 
the majority of upper urinary tract stones.  Its non invasive nature along 
with high efficacy has resulted in outstanding patient and surgeon 
acceptance. 
The success rate of ESWL is determined by factors such as stone 
size, composition location, presence of obstructive changes and 
anatomical anomalies. Stone composition is one hidden factor which 
decides the fragility of calculus and its susceptibility to ESWL. The 
number of shocks required for fragmentation is related not only to the 
size of the stone but also to its hardness (or) brittleness which largely 
depends on its chemical composition. 
Both recommended treatment options, SWL and ureteroscopy, in 
ureteric stone have valid advantages and disadvantages. Supporters of 
SWL claim that it is effective and noninvasive, is associated with less 
morbidity, requires fewer anesthesias than ureteroscopy, and seldom 
requires ureteric stents. Critics argue that the success rates are not as high 
as those of ureteroscopy, equipment availability may be limited, 
visualization of the stone is often difficult, attainment of a stone-free state 
50 
 
requires a longer time and follow-up, re-treatment rates are higher, and 
costs are higher. Supporters of ureteroscopy claim that it is highly 
successful and minimally invasive, is associated with minimal morbidity, 
can be used with larger and multiple stones, and has high immediate 
stone-free rates. Critics argue that it requires specialized training, requires 
more anaesthesia, and more often requires ureteric stent placement.   
The primary goal in treating patients with ureteric calculi is a 
stone-free state, and the AUA/EAU guidelines panel's meta-analytic 
study reported that with ESWL in distal ureteric stone <10mm, in 17 
groups containing 1684 patients stone free rate was 86% (80-91) % 34. In 
our study it was 88%.In >10mm groups containing 966 patients stone free 
rate was 74 %( 57-87) %, in our study it was only 56.5%. All ESWL 
failure cases in our study underwent ureteroscopy and intracorporeal 
pneumatic lithotripsy. All patients were stented following the procedure. 
DJ Stents removed after 3 weeks. During URS &ICL no significant 
abnormality in either ureteric orifice or distal ureteric narrowing below 
the stone was noted. 
 There have been two randomized prospective studies comparing 
ureteroscopy and SWL for treatment of patients with distal ureteric stones 
subsequent to the guidelines document. Peschel and associates (1999) 
randomized 80 patients and found that those undergoing ureteroscopy 
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achieved stone-free status more rapidly, regardless of initial stone size, 
than did those treated by SWL. All of the patients undergoing 
ureteroscopy were rendered stone free, whereas 10% of the SWL cohort 
required subsequent ureteroscopy to achieve a stone-free status35. Pearle 
and associates (2001) randomized 64 patients and reported that 100% of 
individuals who completed radiographic follow-up subsequent to either 
SWL or ureteroscopy became stone free36.  
One possible reason for the difference in this outcome compared 
with the Pearle et al study is that an unmodified Dornier HM3 
lithotripter, which is known to fragment stones more efficiently, was 
used in Pearle's study rather than the Dornier MFL5000 used in 
Peschel's study. In our study overall success rate was 72.9%; 27.1% of 
patients required secondary treatment .The lithotripter used was Dornier 
Compact Delta II (Electromagnetic Generator). 
Joseph et al  assessed the susceptibility of stone fragmentation by 
ESWL according to HU in renal stone, they found that the success rate 
for stone with attenuation value < 1000 HU was significantly higher than 
that for stone with value >1000 HU 37. In their study they found a 
significant correlation between number of shocks required for stone 
fragmentation and the attenuation value of the stone. 
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 Not much of data available in the literature on correlation between 
HU and stone free rate in lower ureteric calculus. In our study significant 
failure and retreatment rates in >1000 HU stones, both in Group 
1(≤10mm) and Group 2(>10mm), but the number of patients in our study 
with HU >1000 were small (8/48).  
KH Yip,PC Tam,CWF Lee,yl leung studied efficacy of insitu 
ESWL in ureteric calculi management using Dornier MFL 5000 
lithotripter, their overall success rate was 81% 38 ,in our study it was 
72.9%. V.J. GNANAPRAGASAM et al studied with same machine 
with success rate of 86%, majority of stone size in this study <10mm39. 
 Mohammad Ghafoor et al studied the efficacy of extracorporeal 
shock wave lithotripsy in the treatment of lower ureteric stones using 
second generation Siemens Lithostar ІІ. Clearance rate for small stones 
(<10mm) in the lower third of the ureter was 73.8% , and for stones 
larger than 10 mm in the distal third of ureter, the clearance rate was low 
42.8% ,  with a high retreatment rate. So Ghafoor et al concluded that for 
distal ureteric stones <10 mm in diameter, the clearance rate is more than 
70% and ESWL can be considered as a primary treatment, while for 
stones larger than 10 mm in diameter, endoscopic removal should be the 
preferred treatment 40. 
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 In our study the results were far better than Ghafoor et al study, 
Clearance rate for small stones (<10mm) was 88% compared with 
73.8%.Clearence rate for stones larger than 10mm was 56.5%  still better 
than Ghafoor et al study  42.8%. 
 In our study total of 48 patients underwent insitu ESWL of lower 
ureteric calculus, 25 patients with stone size ≤10mm and 23 patients with 
> 10mm size. 
Dornier Compact Delta II was used in this study. All procedures were 
done as outpatient treatment. 
 Overall stone free rate was 72.9%, there were 27.1% patients 
required URS/ICL as secondary procedure.  
 In patients with stone size of ≤10mm (Group 1) success rate was 
88%, when C.T H.U was <1000 (Group 1 A) the success rate increased to 
91.7%. 
 In patients with stone size of >10mm (Group 2) success rate was 
56.5%, when C.T H.U was <1000 (Group 2 A) the success rate increased 
to 75%. 
 Patients with CT HU >1000 retreatment and failure rate 
statistically increased when compared to ≤ 1000HU stone patients in both 
groups. 
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 Overall failure rate in ≤10mm (Group 1) was 12%, only one patient 
with CT HU >1000 (Group 1 B) failed to clear the stone.    
 Overall failure rate of insitu ESWL in > 10mm stone size patients 
were 43.5% (Group 2).when C.T H.U was <1000 (Group 2 A) it was only 
25%,in patients with stone size >10mm with C.T H.U (Group 2 B) stone 
clearance failed in all except one - 85.71%.  
 Complications during and following insitu ESWL for lower 
ureteric calculus was minor, no complications required inpatient 
treatment. 
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CONCLUSION 
 
1. Insitu ESWL for lower ureteric calculus is an effective, non 
invasive and a viable treatment option with no major 
complications. 
2. Patients with lower ureteric calculus size ≤ 10 mm and CT – H.U 
<1000 had high expulsion rate with ESWL. Hence ESWL may be 
considered as the primary treatment option. 
3. Other modalities of treatment may be needed in patients with stone 
size >10mm and CT-H.U >1000. 
 
4. Patients with lower ureteric calculus size > 10 mm and CT – H.U 
<1000, ESWL can be tried with reasonable success. 
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NO OF PRIMARY IN ≤ 1000 H.U & >1000 H.U 
  
 
 
 
 
 
 
 
 
STONE SIZE AND SUCCESS RATE 
  
  
 
STONE FREE RATE IN ≤ 10 MM GROUP 
STONE FREE RATE IN >10 MM GROUP 
  
EFFICACY OF ESWL IN LOWER URETERIC 
CALCULUS 
 
                                                 PROFORMA 
  
NAME:                                                AGE & SEX 
 
ADDRESS: 
 
 
 
PHONE NO:                                                           MRD NO:            
 
 
HISTORY: 
 
PAIN – SITE, CHARACTER, DURATION. 
 
HEMATURIA                                                DYSURIA 
 
FEVER                                                            VOMITING 
 
OTHER LUTS; 
 
DM/HT/PT                                                      H/O DRUG INTAKE 
 
PREVIOUS INTERVENTION/ SURGERY 
 
G/E: 
 
 
L/E: 
 
  
GENITALIA: 
P.R: 
PV:  
 
INVESTIGATIONS: 
 
H.B% 
PCV%                                                         URINE: ALB 
                                                                                 SUG 
                                                                                 DEP 
URINE :C/S : 
 
R.F.T:   Bl. UREA 
              Sr.CREATININE            
              Sr.ELECTROLYTES 
              BLOOD SUGAR 
 
 
X RAY KUB: RT/LT                         SIZE- 
 
 
U/S KUB:    HUN - 
 
                     SIZE- 
 
C.T KUB 
 
 
CONSENT 
 
BOWEL PREPARATION 
 
ESWL 
 
 
FOLLOW UP: 
 
15 DAYS: FRAGMENTATION SATISFACTORY/ UNSATISFACTORY 
 
SECOND SITTING- YES/NO 
 
FIRST MONTH:      SYMPTOMS 
                                  X RAY KUB: 
                                  U/S   KUB: 
 
 
SECOND MONTH: SYMPTOMS 
 
                       X RAY KUB: 
 
                                  U/S   KUB: 
 
 
THIRD MONTH:   SYMPTOMS 
 
                                X RAY KUB: 
 
                                 U/S   KUB: 
 
RESULT:                 SUCCESSFUL / FAILURE 
 NO AGE/SEX SIDE SIZE (cms) HU COMORBID NO OF PRIMARY SEC PROCEDURE COMPLICATIONS 
1 24/M LT 1.4x1.2 890 1 PAIN 
2 36/M LT 1.1x1 997 1 
3 43/M RT 1.1x1 782 1 
4 29/M RT 1.5x1.3 >1230 2 URS/ICL&DJ DYSURIA 
5 18/M LT 0.9x0.8 862 1 
6 47/F RT 1.2x1 972 ASTHMA 1 
7 52/M LT 1X0.8 855 2 URS/ICL &DJ DYSURIA 
8 35/M RT 1X0.9 755 1 
9 30/M LT 1.1x1 693 1 
10 21/F LT 1.1X0.9 844 1 DYSURIA 
11 24/M RT 0.7X0.6 993 1 
12 43/M LT 1X0.9 911 1 
13 22/M RT 1.2X1.1 >1050 1 URS/ICL&DJ 
14 49/M RT 0.8X0.6 884 HT&DM 1 HEMATURIA 
15 17/M LT 0.9X0.8 795 1 
16 28/M RT 1X0.9 779 1 HEMATURIA 
17 18/F RT 1X0.8 692 ASTHMA 1 PAIN,DYSURIA 
18 29/F LT 0.8X0.7 592 1 
19 39/M LT 0.6X0.6 783 1 
20 28/F LT 1.1X0.8 880 1 
21 52/M RT 1.5X1 788 HT 2 URS/ICL&DJ HEMATURIA 
22 31/M LT 0.8X0.7 893 1 
23 70/M LT 1.1X1 904 1 URS/ICL&DJ 
24 28/M LT 1X0.9 864 1 URS/ICL&DJ 
25 45/F RT 1.3X1 >1200 HT 2 DYSURIA 
26 29/M LT 1.1X1 764 1 
27 42/M RT 1.1X1 658 1 URS/ICL&DJ 
28 19/M LT 1X0.9 596 1 
29 28/M LT 1.1X0.9 638 1 
30 31/F RT 0.8X0.6 643 1 DYSURIA 
31 52/M LT 1X0.9 851 DM&H.T 1 HEMATURIA, DYSURIA 
32 28/M RT 1.4x1.2 >1100 2 URS/ICL&DJ DYSURIA 
33 19/M LT 1.1X1 869 1 PAIN 
34 49/F RT 1X0.9 866 1 DYSURIA 
35 23/F LT 1.2X1.1 >1270 1 URS/ICL&DJ 
36 43/M RT 1.1X1 778 1 DYSURIA 
37 24/M RT 1X0.8 879 1 
38 21/F LT 1.2XX1 >1410 1 URS/ICL&DJ 
39 30/M RT 1X1 987 1 
               MASTER CHART
NO AGE/SEX SIDE SIZE (cms) HU COMORBID NO OF PRIMARY SEC PROCEDURE COMPLICATIONS 
40 35/M LT 1X0.9 908 1 
41 52/M RT 1.1X1 869 H.T 1 PAIN,DYSURIA 
42 45/F LT 1.5X1.1 756 2 URS/ICL&DJ UTI,DYSURIA 
43 18/M RT 1.2X0.9 >1090 1 URS/ICL&DJ 
44 27/M LT 1X0.9 789 1 HEMATURIA 
45 42/M RT 0.9X0.8 908 1 
46 36/F LT 1X1 698 1 
47 25/M LT 1X0.9 >1110 1 URS/ICL&DJ 
48 35/F LT 0.9X0.9 940 1 
 
 
 
